簡介

本頁面提供了有關 Andrew Reardon 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Andrew Reardon已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:LGND / Ligand Pharmaceuticals Incorporated CLO & Secretary 41,382
如何解讀這些圖表

以下圖表顯示了在Andrew Reardon進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Andrew Reardon 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-06-02 2026-06-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -200 41,382 -0.48 230.41 -46,082 9,534,827
2026-06-02 2026-06-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -1,216 41,582 -2.84 229.47 -279,033 9,541,722
2026-06-02 2026-06-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -584 42,798 -1.35 228.57 -133,487 9,782,501
2026-06-02 2026-06-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -400 43,382 -0.91 226.78 -90,712 9,838,144
2026-06-02 2026-06-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -1,432 43,782 -3.17 225.97 -323,585 9,893,296
2026-06-02 2026-06-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -677 45,214 -1.48 225.20 -152,459 10,182,116
2026-06-02 2026-06-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -491 45,891 -1.06 223.95 -109,958 10,277,138
2026-06-02 2026-06-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,000 46,382 12.08 52.27 261,350 2,424,387
2026-05-04 2026-05-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -800 41,382 -1.90 234.02 -187,214 9,684,120
2026-05-04 2026-05-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -1,420 42,182 -3.26 232.92 -330,749 9,825,116
2026-05-04 2026-05-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -780 43,602 -1.76 232.04 -180,991 10,117,404
2026-05-04 2026-05-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -370 44,382 -0.83 230.87 -85,422 10,246,437
2026-05-04 2026-05-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -98 44,752 -0.22 229.71 -22,511 10,279,919
2026-05-04 2026-05-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -932 44,850 -2.04 228.75 -213,198 10,259,603
2026-05-04 2026-05-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -600 45,782 -1.29 227.45 -136,470 10,413,084
2026-05-04 2026-05-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,000 46,382 12.08 52.27 261,350 2,424,387
2026-04-02 2026-04-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -337 41,382 -0.81 204.50 -68,917 8,462,727
2026-04-02 2026-04-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -963 41,719 -2.26 203.22 -195,703 8,478,210
2026-04-02 2026-04-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -700 42,682 -1.61 201.90 -141,328 8,617,372
2026-04-02 2026-04-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -1,238 43,382 -2.77 200.94 -248,767 8,717,305
2026-04-02 2026-04-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -1,302 44,620 -2.84 199.72 -260,038 8,911,600
2026-04-02 2026-04-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -460 45,922 -0.99 198.85 -91,471 9,131,558
2026-04-02 2026-04-01 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,000 46,382 12.08 52.27 261,350 2,424,387
2026-03-27 2026-03-02 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 4,513 41,382 12.24
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -1,142 36,869 -3.00 208.87 -238,532 7,700,917
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -1,446 38,011 -3.66 208.12 -300,939 7,910,785
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -612 39,457 -1.53 207.01 -126,689 8,167,950
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -340 40,069 -0.84 206.37 -70,165 8,268,919
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -460 40,409 -1.13 205.18 -94,382 8,291,038
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -200 40,869 -0.49 204.17 -40,834 8,344,224
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -300 41,069 -0.73 201.70 -60,510 8,283,617
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -93 41,369 -0.22 200.62 -18,658 8,299,552
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -207 41,462 -0.50 199.96 -41,391 8,290,576
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -100 41,669 -0.24 199.00 -19,900 8,292,339
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale X -100 41,769 -0.24 197.70 -19,770 8,257,539
2026-03-06 2026-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise X 5,000 41,869 13.56 52.27 261,350 2,188,493
2026-02-18 2026-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -992 36,869 -2.62 183.83 -182,359 6,777,628
2026-02-18 2026-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -801 37,861 -2.07 183.83 -147,248 6,959,988
2026-02-18 2026-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -593 38,662 -1.51 183.83 -109,011 7,107,235
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -4,083 39,255 -9.42 183.83 -750,578 7,216,247
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 8,810 43,338 25.52
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -3,211 34,528 -8.51 183.83 -590,278 6,347,282
2026-02-18 2026-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,928 37,739 22.49
2025-08-12 2025-08-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,325 30,811 -4.12 150.06 -198,830 4,623,499
2025-07-02 2025-06-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 233 32,136 0.73 91.08 21,221 2,926,867
2025-06-24 2025-06-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -500 31,903 -1.54 114.08 -57,042 3,639,631
2025-06-12 2025-06-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -500 32,403 -1.52 114.54 -57,271 3,711,485
2025-06-02 2025-05-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1,000 32,903 -2.95 104.00 -104,000 3,421,912
2025-06-02 2024-08-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -897 21,637 -3.98 100.16 -89,839 2,167,054
2025-03-06 2025-03-04 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,415 34,783 22.61
2025-02-19 2025-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -876 28,368 -3.00 120.00 -105,120 3,404,160
2025-02-19 2025-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,114 29,244 -3.67 120.00 -133,680 3,509,280
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,758 30,358 -5.47 120.00 -210,960 3,642,960
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5,429 32,116 20.34
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -2,775 26,687 -9.42 120.00 -333,000 3,202,440
2025-02-19 2025-02-14 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 6,928 29,462 30.74
2024-09-25 2024-09-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -2,000 22,534 -8.15 99.60 -199,201 2,244,398
2024-09-25 2024-09-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 2,000 24,534 8.88 52.27 104,540 1,282,392
2024-08-30 2024-08-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -1,500 22,534 -6.24 106.39 -159,591 2,397,476
2024-08-30 2024-08-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 1,500 24,034 6.66 52.27 78,405 1,256,257
2024-07-02 2024-06-28 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 329 22,534 1.48 60.71 19,973 1,367,972
2024-05-13 2024-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -10,000 22,205 -31.05 83.04 -830,449 1,844,012
2024-05-13 2024-05-09 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
M - Exercise 10,000 32,205 45.03 52.27 522,700 1,683,355
2024-02-29 2024-02-27 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 7,208 22,205 48.06
2024-02-16 2024-02-15 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -593 14,997 -3.80 74.65 -44,267 1,119,526
2024-01-04 2023-12-29 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
J - Other 179 15,590 1.16 60.71 10,867 946,422
2023-08-14 2023-08-10 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -897 15,411 -5.50 68.73 -61,651 1,059,198
2023-03-28 2023-03-24 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
S - Sale -300 16,308 -1.81 69.92 -20,977 1,140,325
2023-02-27 2023-02-23 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
A - Award 5,668 16,608 51.81
2022-12-01 2022-11-30 4 LGND LIGAND PHARMACEUTICALS INC
Common Stock
F - Taxes -1,073 10,940 -8.93 72.90 -78,222 797,526
2022-11-07 3 LGND LIGAND PHARMACEUTICALS INC
Common Stock
12,013
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)